NephroPlus Sets GUINNESS WORLD RECORDS™ title for Largest Kidney Health Screening Drive

▴ NephroPlus
NephroPlus plans to further its kidney health awareness efforts in the upcoming years. The insights gathered from this campaign will contribute to further research and advocacy efforts, ensuring greater access to early diagnosis and preventive care for millions across India.

Mumbai, 17th March 2025: NephroPlus, Asia’s largest dialysis care network, has achieved a monumental milestone by setting a GUINNESS WORLD RECORDS title for the ‘Most people to sign up for a kidney health screening online in one week with 10,501 sign-ups within the period of 6th – 11th March, 2025.
The free kidney screening camps, organized under the slogan ‘Are Your Kidneys OK? Detect Early and Protect Kidney Health,’ received an overwhelming response from thousands of participants. The initiative specifically targeted high-risk individuals, including those with diabetes and hypertension, emphasizing the critical importance of early detection in preventing kidney disease. Major cities covered in the campaign included Bengaluru, Delhi, Jaipur, Pune, Hyderabad, Lucknow, and Ranchi among others.
On this occasion, NephroPlus also launched a groundbreaking study on Chronic Kidney Disease (CKD). With the extensive offline data collected through these screenings, the company plans to publish a white paper and a manuscript in a reputed academic journal—most likely the first-ever global white paper on CKD prevention. This marks a significant milestone in the global fight against CKD and reinforces NephroPlus’ leadership in kidney health innovation.

Vikram Vuppala, Group CEO and Founder of NephroPlus, said: “This remarkable accomplishment highlights our unwavering commitment to raising awareness about kidney health in a country where CKD prevalence ranges from 12% to 21% across different regions. Many cases remain undiagnosed until the advanced stages, which underscores the need for large-scale, preventive health interventions. Setting two world records simultaneously reflects the unprecedented scale of our initiative and our determination to bring life-saving early detection to communities with limited access to specialized healthcare.” He further added: “The launch of our CKD prevention study is a game-changer. Governments worldwide need to recognize that CKD prevention is not just a health initiative—it’s a strategic economic investment. The insights from this study will drive advocacy for increased government funding and policy changes focused on early detection and intervention. We believe this could have a lasting impact on global healthcare frameworks.”

The CKD white paper will emphasize why governments should prioritize CKD prevention, not only as a public health measure but also as a long-term economic strategy. Early intervention can reduce healthcare costs, prevent productivity loss, and improve the overall quality of life for millions. This pioneering research sets NephroPlus apart as the global leader in CKD prevention and treatment innovation.

Building on this achievement, NephroPlus plans to further its kidney health awareness efforts in the upcoming years. The insights gathered from this campaign will contribute to further research and advocacy efforts, ensuring greater access to early diagnosis and preventive care for millions across India.
The link to the above mentioned White paper: https://worldkidneyday.nephroplus.com/analysis
Photo caption: Vikram Vuppala, Group CEO & Founder, Kamal D Shah, Co-founder - NephroPlus alongwith NephroPlus' senior leadership

About NephroPlus:
NephroPlus operates 500+ dialysis clinics in more than 300+ cities across 5 countries and is known for its quality focus and patient-centricity. The company was established 14 years back with a vision to enable people on dialysis across the world to lead long, happy, and productive lives. The company treats ~32,000 patients per month.

For further information: https://www.NephroPlus.com/

For more information contact:
Madison Public Relations
Shakun Sharma– shakun.sharma@madisonpr.in | 9136515137
Gunjan Mehra – gunjan.mehra@madisonpr.in | 9870424484

Tags : #NephroPlus #KidneyDisease #KidneyHealth #healthcareinnovation

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026